Back
Keros Therapeutics Vs. ADMA Biologics Industry Stock Comparison
Buy
62
KROS
Keros Therapeutics
Last Price:
56.44
Seasonality Move:
54.08%
Buy
73
ADMA
ADMA Biologics
Last Price:
19.38
Seasonality Move:
-5.57%
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $56.45. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
ADMA Biologics (ADMA)
is a Buy
Is ADMA Biologics a Buy, Sell or Hold?
- The current ADMA Biologics [ADMA] share price is $19.39. The Score for ADMA is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- ADMA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $56.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
ADMA Stock Price Chart
What is ADMA Biologics's stock price today?
-
The ADMA Biologics share price today is $19.39
The current trend is moderately bullish and ADMA is experiencing slight buying pressure.
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.11 | Buy |
Relative Strength Index (14 RSI): | 62.18 | Buy |
Chaikin Money Flow: | -153833 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.11 - 57.09) | Buy |
Bollinger Bands (100): | (45.06 - 53.7) | Buy |
ADMA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.94 | Buy |
Relative Strength Index (14 RSI): | 62.56 | Buy |
Chaikin Money Flow: | -42876 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.98 - 19.28) | Buy |
Bollinger Bands (100): | (9.74 - 17.02) | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.1 | Buy |
20-day SMA: | 54.42 | Buy |
50-day SMA: | 50.2 | Buy |
200-day SMA: | 52.84 | Buy |
8-day EMA: | 56 | Buy |
20-day EMA: | 54.17 | Buy |
50-day EMA: | 51.53 | Buy |
200-day EMA: | 49.92 | Buy |
ADMA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.58 | Sell |
20-day SMA: | 18.28 | Buy |
50-day SMA: | 16.31 | Buy |
200-day SMA: | 9.46 | Buy |
8-day EMA: | 19.3 | Buy |
20-day EMA: | 18.51 | Buy |
50-day EMA: | 16.55 | Buy |
200-day EMA: | 10.91 | Buy |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.
ADMA Biologics Earnings Growth & ADMA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.04 per share, an increase this year of $0.51 per share, and an increase next year of $0.17 per share.
Keros Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ADMA Biologics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |